Cidara Therapeutics Inc (NASDAQ:CDTX) has a beta value of 0.80 and has seen 3.7 million shares traded in the recent trading session. The company, currently valued at $526.65M, closed the recent trade at $171600.0 per share which meant it gained $171578.98 on the day or 3699301% during that session. The CDTX stock price is 99.98% off its 52-week high price of $28.42 and 99.99% above the 52-week low of $10.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.23 million shares traded. The 3-month trading volume is 171.60K shares.
The consensus among analysts is that Cidara Therapeutics Inc (CDTX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Cidara Therapeutics Inc (NASDAQ:CDTX) trade information
Over the past 30 days, the shares of Cidara Therapeutics Inc (NASDAQ:CDTX) have changed 54.69%. Short interest in the company has seen 0.47 million shares shorted with days to cover at 3.12.
Wall Street analysts have a consensus price target for the stock at $48, which means that the shares’ value could drop -357400.0% from the levels at last check today.. The projected low price target is $46.0 while the price target rests at a high of $50.0. In that case, then, we find that the latest price level in today’s session is 99.97% off the targeted high while a plunge would see the stock lose 99.97% from the levels at last check today..
Cidara Therapeutics Inc (CDTX) estimates and forecasts
The company’s shares have gained 78.02% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 1.30% over the past 5 years. Earnings growth for 2025 is a modest 71.36% while over the next 5 years, the company’s earnings are expected to increase by 36.81%.
CDTX Dividends
Cidara Therapeutics Inc is expected to release its next earnings report on 2025-May-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cidara Therapeutics Inc (NASDAQ:CDTX)’s Major holders
Insiders own 1.74% of the company shares, while shares held by institutions stand at 86.20% with a share float percentage of 87.73%. Investors are also buoyed by the number of investors in a company, with Cidara Therapeutics Inc having a total of 58.0 institutions that hold shares in the company. The top two institutional holders are MONASHEE INVESTMENT MANAGEMENT LLC with over 0.37 million shares worth more than $4.41 million. As of 2024-06-30, MONASHEE INVESTMENT MANAGEMENT LLC held 8.0876% of shares outstanding.
The other major institutional holder is BVF INC/IL, with the holding of over 0.34 million shares as of 2024-06-30. The firm’s total holdings are worth over $4.1 million and represent 7.5169% of shares outstanding.
